Some women are reporting that taking GLP-1 injections, more commonly known by brand names like Ozempic and Mounjaro, has ...

Doctors and many patients say GLP-1 drugs can help solve the growing problem of obesity. But some bristle at the thought that ...

Maziar Mike Doustdar takes office as NVO's new CEO, bringing a proven global growth record to tackle rising obesity market ...

Loss Drug to Irreversible Blindness A growing wave of lawsuits is targeting Novo Nordisk, the manufacturer of the widely used ...

Glucagon-like peptide 1 receptor agonists, including semaglutide, have increased in use and will continue to increase due to their effectiveness in weight loss.

Many Mounjaro users are looking into alternative medications following news of a 170 percent price increase in the UK ...

Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist taken as a ...

MAKERS of the fat jab Wegovy say they will not increase the price of the drug when the cost of rival Mounjaro doubles next ...

UK plant-based pet food brand Omni has launched LeanPaws, a patent-pending weight loss supplement for dogs. According to Omni ...

In a virtual meeting with health care providers and community partners Thursday afternoon, North Carolina Health Secretary ...

By Dennis Thompson HealthDay ReporterFRIDAY, Aug. 15, 2025 (HealthDay News) — “Forever” PFAS chemicals might hamper a teenager’s ability to drop excess weight, even if they’ve undergone weight-loss ...